Source: The Scientist

Polycystic ovary syndrome (PCOS), a condition associated with ovarian cyst development and one of the leading causes of female infertility, remains one of the most misunderstood hormonal disorders affecting women despite years of medical attention. Now, the condition is being given a new name in an effort to broaden its medical scope and better reflect its complexity.

As of today, a growing number of scientists and healthcare professionals are referring to the disorder as poly-metabolic ovarian syndrome, or PMOS, arguing that the previous name placed too much focus on ovarian cysts while overlooking the many other factors that contribute to the condition and its wider impact on the body.

Officially introduced on May 12, 2026, the renaming was driven by a landmark global consensus published in The Lancet. Backed by 56 leading medical experts and patient organizations worldwide, the change is based on the recognition that many patients diagnosed with PCOS do not actually develop ovarian cysts, despite experiencing other hallmark symptoms of the disorder. Researchers have described the term as misleading and limiting, arguing that it fails to capture the condition's broader clinical spectrum and may contribute to misdiagnosis and delayed treatment.

In contrast, PMOS reframes the disorder as a more complex metabolic and hormonal condition linked to a range of significant health concerns, including insulin resistance, inflammation, weight changes, fertility problems, and an increased risk of diabetes and cardiovascular disease.

With the proposed wider adoption of the term PMOS, researchers believe it could help both patients and clinicians better recognize the condition as a whole-body disorder rather than solely a reproductive issue. Medical experts who support the name change also hope it will encourage a more holistic approach to management and provide more comprehensive care addressing metabolic health alongside fertility and menstrual symptoms.

Experts also warn that continued use of outdated terminology may contribute to years of underdiagnosis, potentially placing patients' health at risk, particularly those who do not fit the traditional presentation associated with ovarian cysts. The debate over renaming the condition has gained traction in recent years as studies continue to highlight the extent to which PCOS can affect multiple organ systems.

As PCOS continues to affect millions of women worldwide, the proposed PMOS terminology has not yet been universally adopted. However, by shedding light on the broader range of symptoms included under PMOS, its supporters believe the shift could improve awareness, reduce stigma, and lead to earlier intervention for patients struggling with the condition.